By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

NeuroSigma, Inc. 

10960 Wilshire Boulevard
Suite 1230
Los Angeles  California  90024  U.S.A.
Phone: 310-479-3100 Fax: n/a


SEARCH JOBS


Industry
Medical Device






Company News
Enrollment Commences In NeuroSigma, Inc.-Sponsored Pediatric Clinical Trial For The Treatment Of Lennox-Gastaut Syndrome 7/22/2014 11:25:04 AM
National Institutes of Health (NIH) Funds Phase 2 Clinical Trial At University of California, Los Angeles (UCLA) For The Treatment Of ADHD With NeuroSigma, Inc.'s eTNS Systemnational 7/9/2014 9:28:00 AM
NeuroSigma, Inc. Release: Advances In Trigeminal Nerve Stimulation Featured At European Congress On Epileptology In Stockholm, Sweden 7/8/2014 9:32:56 AM
NeuroSigma, Inc. Receives Approval From Australian Therapeutic Goods Administration To Market Its Monarch ™ Etns ™ System For The Adjunctive Treatment Of Drug-Resistant Epilepsy 4/1/2014 7:18:13 AM
NeuroSigma, Inc. Signs On Two Former Amgen (AMGN) Finance Executives 3/28/2014 6:20:07 AM
David Hayes, Former Partner At O'Melveny & Myers LLP And Haynes And Boone LLP, Joins NeuroSigma, Inc. As Chief Administrative Officer, General Counsel And Sr. Vice President 2/25/2014 6:50:08 AM
Former Amgen (AMGN) Finance Executive Carl Adams Joins NeuroSigma, Inc. As Vice President And Controller 2/11/2014 10:04:23 AM
Former Allergan Inc. (AGN) Marketing Executive Gregory F. Brooks Joins NeuroSigma, Inc. As Senior VP And Chief Commercial Officer 1/27/2014 9:33:22 AM
NeuroSigma, Inc. Release: External Trigeminal Nerve Stimulation (eTNS) Presentations At The American Epilepsy Society 1/21/2014 6:33:37 AM
NeuroSigma, Inc. Gets FDA Approval to Commence Phase 3 Epilepsy DeviceTrial 7/29/2013 7:52:03 AM
1234
//-->